Interleukin-1α-889 C/T Polymorphism in Turkish Patients with Late-Onset Alzheimer's Disease

被引:14
作者
Dursun, Erdinc [1 ,2 ]
Gezen-Ak, Duygu [1 ,2 ]
Ertan, Turan
Bilgic, Basar [5 ]
Gurvit, Hakan [4 ]
Emre, Murat [4 ]
Eker, Engin
Engin, Funda
Uysal, Oemer [3 ]
Yilmazer, Selma [1 ,2 ]
机构
[1] Istanbul Univ, Cerrahpasa Fac Med, Dept Med Biol, Istanbul, Turkey
[2] Istanbul Univ, Cerrahpasa Fac Med, Dept Geropsychiat, Istanbul, Turkey
[3] Istanbul Univ, Cerrahpasa Fac Med, Dept Biostat, Istanbul, Turkey
[4] Istanbul Univ, Istanbul Fac Med, Dept Neurol, Behav & Movement Disorders Unit, Istanbul, Turkey
[5] Istanbul Neuropsychiat Hosp, Dept Neurol, Istanbul, Turkey
关键词
Alzheimer's disease; Inflammation; Interleukin-1; gene; Polymorphism; Polymerase chain reaction with confronting two-pair primers; Brain aging; AMYLOID BETA-PROTEIN; GENE POLYMORPHISMS; COMPLEX DISEASE; ASSOCIATION; CYTOKINES; RISK; INFLAMMATION; INTERLEUKIN; NEUROINFLAMMATION; ASTROCYTES;
D O I
10.1159/000193627
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background/Aims: The polymorphism (rs1800587) in the 5'-flanking regulatory region at -889 of the interleukin-1 alpha gene has been shown to be associated with inflammatory diseases and Alzheimer's disease (AD). The aim of the current study is to determine whether there is an association between the promoter region polymorphism of the interleukin-1 alpha gene and late-onset AD in a cohort of Turkish patients. Methods: One hundred and four subjects with dementia of the Alzheimer type and 103 age-matched controls were genotyped according to the PCR with confronting two-pair primers method. Results: Although the distribution of genotypes did not significantly differ (p = 0.107), the difference between allelic frequency was nearly significant according to a chi(2) test ( p = 0.05) when the controls and patients were compared. Conclusion: Our results showed that there is no association between the -889 C/T transition on the interleukin-1 alpha gene and late-onset AD in the Turkish population. Copyright (c) 2009 S. Karger AG, Basel
引用
收藏
页码:82 / 87
页数:6
相关论文
共 52 条
[1]   Inflammation and Alzheimer's disease [J].
Akiyama, H ;
Barger, S ;
Barnum, S ;
Bradt, B ;
Bauer, J ;
Cole, GM ;
Cooper, NR ;
Eikelenboom, P ;
Emmerling, M ;
Fiebich, BL ;
Finch, CE ;
Frautschy, S ;
Griffin, WST ;
Hampel, H ;
Hull, M ;
Landreth, G ;
Lue, LF ;
Mrak, R ;
Mackenzie, IR ;
McGeer, PL ;
O'Banion, MK ;
Pachter, J ;
Pasinetti, G ;
Plata-Salaman, C ;
Rogers, J ;
Rydel, R ;
Shen, Y ;
Streit, W ;
Strohmeyer, R ;
Tooyoma, I ;
Van Muiswinkel, FL ;
Veerhuis, R ;
Walker, D ;
Webster, S ;
Wegrzyniak, B ;
Wenk, G ;
Wyss-Coray, T .
NEUROBIOLOGY OF AGING, 2000, 21 (03) :383-421
[2]   Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E [J].
Barger, SW ;
Harmon, AD .
NATURE, 1997, 388 (6645) :878-881
[3]   Association of IL-1 RN*2 allele and methionine synthase 2756 AA genotype with dementia severity of sporadic Alzheimer's disease [J].
Bosco, P ;
Guéant-Rodríguez, RM ;
Anello, G ;
Romano, A ;
Namour, B ;
Spada, RS ;
Caraci, F ;
Tringali, G ;
Ferri, R ;
Guéant, JL .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (07) :1036-1038
[4]   Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice [J].
Citron, M ;
Westaway, D ;
Xia, WM ;
Carlson, G ;
Diehl, T ;
Levesque, G ;
JohnsonWood, K ;
Lee, M ;
Seubert, P ;
Davis, A ;
Kholodenko, D ;
Motter, R ;
Sherrington, R ;
Perry, B ;
Yao, H ;
Strome, R ;
Lieberburg, I ;
Rommens, J ;
Kim, S ;
Schenk, D ;
Fraser, P ;
Hyslop, PS ;
Selkoe, DJ .
NATURE MEDICINE, 1997, 3 (01) :67-72
[5]   Gene dose-dependent association of interleukin-1A [-889] allele 2 polymorphism with Alzheimer's disease [J].
Combarros, O ;
Sánchez-Guerra, M ;
Infante, J ;
Llorca, J ;
Berciano, J .
JOURNAL OF NEUROLOGY, 2002, 249 (09) :1242-1245
[6]   Association of an interleukin 1α polymorphism with Alzheimer's disease [J].
Du, Y ;
Dodel, RC ;
Eastwood, BJ ;
Bales, KR ;
Gao, F ;
Lohmüller, F ;
Müller, U ;
Kurz, A ;
Zimmer, R ;
Evans, RM ;
Hake, A ;
Gasser, T ;
Oertel, WH ;
Griffin, WST ;
Paul, SM ;
Farlow, MR .
NEUROLOGY, 2000, 55 (04) :480-483
[7]   SNP association studies in Alzheimer's disease highlight problems for complex disease analysis [J].
Emahazion, T ;
Feuk, L ;
Jobs, M ;
Sawyer, SL ;
Fredman, D ;
St Clair, D ;
Prince, JA ;
Brookes, AJ .
TRENDS IN GENETICS, 2001, 17 (07) :407-413
[8]   Interleukin-1A polymorphism is not associated with late onset Alzheimer's disease [J].
Fidani, L ;
Goulas, A ;
Mirtsou, V ;
Petersen, RC ;
Tangalos, E ;
Crook, R ;
Hardy, J .
NEUROSCIENCE LETTERS, 2002, 323 (01) :81-83
[9]   Are interleukin-1 gene polymorphisms risk factors or disease modifiers in AD? [J].
Green, EK ;
Harris, JM ;
Lemmon, H ;
Lambert, JC ;
Chartier-Harlin, MC ;
St Clair, D ;
Mann, DMA ;
Iwatsubo, T ;
Lendon, CL .
NEUROLOGY, 2002, 58 (10) :1566-1568
[10]  
GRIFFIN WST, 1995, J NEUROPATH EXP NEUR, V54, P276